1. Home
  2. CRGX vs FUNC Comparison

CRGX vs FUNC Comparison

Compare CRGX & FUNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • FUNC
  • Stock Information
  • Founded
  • CRGX 2021
  • FUNC 1900
  • Country
  • CRGX United States
  • FUNC United States
  • Employees
  • CRGX N/A
  • FUNC N/A
  • Industry
  • CRGX
  • FUNC Major Banks
  • Sector
  • CRGX
  • FUNC Finance
  • Exchange
  • CRGX Nasdaq
  • FUNC Nasdaq
  • Market Cap
  • CRGX 213.5M
  • FUNC 213.0M
  • IPO Year
  • CRGX 2023
  • FUNC N/A
  • Fundamental
  • Price
  • CRGX $4.52
  • FUNC $34.11
  • Analyst Decision
  • CRGX Hold
  • FUNC
  • Analyst Count
  • CRGX 7
  • FUNC 0
  • Target Price
  • CRGX $5.33
  • FUNC N/A
  • AVG Volume (30 Days)
  • CRGX 3.0M
  • FUNC 70.4K
  • Earning Date
  • CRGX 08-11-2025
  • FUNC 07-21-2025
  • Dividend Yield
  • CRGX N/A
  • FUNC 2.60%
  • EPS Growth
  • CRGX N/A
  • FUNC 62.97
  • EPS
  • CRGX N/A
  • FUNC 3.66
  • Revenue
  • CRGX N/A
  • FUNC $81,451,000.00
  • Revenue This Year
  • CRGX $57.81
  • FUNC $14.15
  • Revenue Next Year
  • CRGX N/A
  • FUNC $7.07
  • P/E Ratio
  • CRGX N/A
  • FUNC $9.27
  • Revenue Growth
  • CRGX N/A
  • FUNC 16.98
  • 52 Week Low
  • CRGX $3.00
  • FUNC $24.66
  • 52 Week High
  • CRGX $25.45
  • FUNC $42.50
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 54.72
  • FUNC 57.34
  • Support Level
  • CRGX $4.40
  • FUNC $33.15
  • Resistance Level
  • CRGX $4.63
  • FUNC $36.57
  • Average True Range (ATR)
  • CRGX 0.07
  • FUNC 1.41
  • MACD
  • CRGX -0.01
  • FUNC -0.01
  • Stochastic Oscillator
  • CRGX 34.29
  • FUNC 48.51

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

About FUNC First United Corporation

First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.

Share on Social Networks: